Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention.
Saved in:
Main Authors: | Diana N J Lockwood (Author), Padebettu Krishnamurthy (Author), Bhushan Kumar (Author), Gerson Penna (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trend analysis of leprosy in Morocco between 2000 and 2017: Evidence on the single dose rifampicin chemoprophylaxis.
by: Ibtissam Khoudri, et al.
Published: (2018) -
Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
by: Willemijn J Idema, et al.
Published: (2010) -
Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022) -
Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma.
by: Niraj Parajuli, et al.
Published: (2021) -
Chemoprophylaxis of Tropical Infectious Diseases
by: William J. H. McBride
Published: (2010)